Notifications
9 minutes, 14 seconds
-2 Views 0 Comments 0 Likes 0 Reviews
United States Next-Generation Sequencing Market Trends & Summary
Market Overview
The United States next-generation sequencing (NGS) market is experiencing substantial growth, projected to expand from US$ 3.16 billion in 2023 to US$ 13.75 billion by 2032, reflecting a compound annual growth rate (CAGR) of 17.75% from 2024 to 2032. This rapid expansion is fueled by advancements in genomics technology, rising adoption of biotechnology and pharmacogenomics, and increased investment in research and development within the healthcare and biotechnology sectors.
Free Download Sample Report: https://www.renub.com/request-sample-page.php?gturl=united-states-next-generation-sequencing-market-p.php
Key Market Segments
The United States Next-Generation Sequencing Market & Forecast report categorizes the market based on:
By Product:
By Application:
By Technology:
By End-Users:
Market Outlook
NGS has revolutionized genomics, enabling large-scale DNA sequencing in a cost-effective and efficient manner. Unlike traditional methods, NGS can process millions of DNA fragments in a single run, enhancing its use in various fields, including medicine, agriculture, and environmental research.
Applications in Healthcare
NGS plays a crucial role in precision medicine, cancer treatment, and prenatal diagnostics. It helps identify genetic mutations that determine treatment plans for cancer patients and facilitates pathogen evolution studies for epidemiological investigations. Oncology applications are particularly significant, with over 2,001,140 new cancer cases and 611,720 cancer deaths projected in the U.S. in 2024, according to the American Cancer Society.
Applications in Agriculture and Environment
In agriculture, NGS aids in crop breeding, enhancing plant resilience and productivity. In environmental science, it is used for biodiversity assessments and ecosystem surveys.
Growth Drivers
1. Rising Demand for Personalized Medicine
NGS is a cornerstone of personalized medicine, allowing healthcare providers to tailor treatments based on an individual’s genetic profile. With increasing awareness of genetic testing, investment in NGS technology and services is expanding.
2. Advancements in NGS Technology
Continuous improvements in sequencing technology are reducing costs and increasing efficiency. Innovations in bioinformatics tools and software are further driving market adoption. A notable development is QIAGEN's acquisition of Verogen in January 2023, strengthening its NGS product portfolio.
3. Growing Applications in Research and Clinical Diagnostics
NGS is widely used in genomics, transcriptomics, and epigenomics research. Regulatory approvals for NGS-based tests are boosting adoption in clinical settings. The American Rescue Plan funded $1.7 billion for genomic surveillance in 2022, with $90 million allocated to the Pathogen Genomics Centers of Excellence.
Market Challenges
1. High Cost of Implementation
Despite technological advancements, the high cost of sequencing equipment and bioinformatics tools poses a barrier to widespread adoption. Additionally, inconsistent reimbursement policies limit the accessibility of NGS-based diagnostics.
2. Data Storage and Privacy Concerns
NGS generates vast amounts of genomic data, requiring sophisticated storage solutions and high-performance computing. Ensuring data privacy and compliance with regulations like HIPAA remains a challenge.
Key Market Segments Analysis
Reagents & Consumables Market
This segment is crucial due to the continuous need for sequencing reagents in clinical and research applications. However, supply chain disruptions and regulatory approvals affect growth.
NGS in Diagnostics
NGS has transformed disease diagnostics, enabling early detection of genetic disorders and cancer. Despite high costs and complex regulatory pathways, efforts to improve standardization and expand insurance coverage are enhancing accessibility.
NGS in Drug Discovery
The pharmaceutical industry leverages NGS for identifying genetic markers, studying disease mechanisms, and screening drug candidates. However, bioinformatics limitations and regulatory hurdles impact commercialization.
Sequencing by Synthesis (SBS) Market
SBS, dominated by Illumina, remains the most widely used sequencing method due to its accuracy. Despite challenges such as high equipment costs and proprietary chemistry restrictions, continuous improvements in sequencing speed and cost-effectiveness drive adoption.
Hospitals and Clinics Market
NGS adoption in U.S. hospitals is growing, particularly in personalized medicine and oncology diagnostics. However, smaller hospitals and community clinics face financial and technical barriers. Initiatives to make NGS more affordable and accessible are underway.
Recent Company Developments
Key Industry Players:
Notable Collaborations and Product Launches:
Conclusion
The United States Next-Generation Sequencing Market is poised for significant growth, driven by technological advancements, increasing demand for precision medicine, and expanding research applications. However, challenges such as high costs, data privacy concerns, and reimbursement limitations must be addressed to ensure widespread adoption. Strategic collaborations, regulatory advancements, and continued investment in bioinformatics and sequencing technology will be key to sustaining market momentum through 2032.
About Us
Renub Research is a leading market research and advisory firm with over 15 years of experience in providing business-to-business global market research, business surveys, and management consulting. Our firm is dedicated to offering a comprehensive suite of services tailored to help businesses make informed decisions.
We partner with our clients to identify their greatest opportunities, address pressing issues, and navigate the changes required to drive success. Our clients span across various high-stakes industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecoms & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.
Our Expertise
Renub Research is trusted by top global organizations for our deep insights, actionable market information, and precise market data that empower our clients to make well-informed decisions. We are a well-established provider of industry solutions, and our research is pivotal in assisting consultants, bankers, and executives with crafting solid business strategies.
Our team consists of highly skilled professionals with expertise in finance, marketing, human resources, biotechnology, pharmaceuticals, IT, environmental science, and other related fields. The studies we conduct form the foundation of management decisions, including strategies, organizational structures, activities, technology use, and merger and acquisition opportunities.
Why Choose Renub Research?
